EnSilica announces strong FY24 performance marked by record revenues and profit, driven by key contract wins and evolving relationships with suppliers. The chip maker projects accelerated growth in FY25, fueled by strong market demand and strategic expansion.
Prospex Energy marks a year of milestones after adding a second producing asset and eliminating all debt in FY23. With significant upside across its two assets and stable commodity markets, the company is well-positioned for continued growth.
CleanTech Lithium has produced and shipped a concentrated lithium product that derived from its Laguna Verde project in Chile
Vox Markets speaks to Dr Ilian Iliev, CEO of deep tech investor NetScientific, about the transformational acquisition of Martlet Capital, a deal which doubles its assets under management and deepens its connections into Cambridge's world-leading innovation hotspot, Silicon Fen.
NetScientific solidifies its position in the deep tech and life sciences sectors by securing an investment management mandate with Martlet Capital and acquiring its operational business.
Shield Therapeutics reports 2.8x revenue growth in FY23, driven by increasing adoption of Accrufer in the US. The company also highlights significant operational progress, including a paediatric study and ongoing expansion into Canada, China, and Korea.
England expects it could be a tricky night for Rishi Sunak – can he survive until the General Election? And will the Tory party survive in the long run? Helen Thomas, former advisor to George Osborne, is here to discuss.
Essentially Group successfully wraps up acquisition of Best of Latin Foodstuff Trading LLC and appoints Catalina Oñate as Executive Director.
Polarean Imaging secures a major new order for its Xenon MRI System from the University of Alabama at Birmingham (UAB) Hospital, marking its second de novo acquisition in the US. POLX shares jumped 44% on the news.
88 Energy ramps up exploration of its PEL 93 acreage in onshore Namibia with the award of a 2D seismic contract, aiming to validate leads and pursue a maiden resource declaration in the Owambo Basin.
On Todays Exchange we are planning to cover a number of 'popular' companies such as Avacta , XP Factory, Cornerstone FS, Journeo, Loungers & many others.
Light Science Technologies expands its Controlled Environment Agriculture division's market reach by partnering with AgriLogiq for exclusive distribution in South Africa, tapping into the region's burgeoning agricultural market.
Strategic Minerals advances its Redmoor Copper-Tungsten-Tin project in Cornwall with extensive core re-logging and sampling, while initiating promising recon exploration in the newly acquired Tamar Valley license area.
Vox Markets speaks to Simon Deacon, CEO of Light Science Technologies (LST), about a year which has seen rapid revenue growth and judicious cost management move the controlled environment agriculture and passive fire protection specialist move close to self-financing growth as it eyes global expansion.
Cornerstone FS, trading as Finseta, announces a stellar 100% revenue surge to £9.6m and first-ever profitability, bolstered by an expansion of its global payments network and securing regulatory approval in Canada.
XP Factory's Q1 results showcase substantial double-digit growth, driven by strong performance in both Escape Hunt and Boom Battle Bar brands, aligning with market projections for the fiscal year ending March 31, 2024.
Polarean Imaging will showcase its novel Xenon MRI technology at the ATS 2024 Respiratory Innovation Summit, highlighting advancements in lung imaging and fostering partnerships within the pulmonary medicine community.
In this interview, CEO James Hickman and CFO Judy Happe of Cornerstone FS (soon to be renamed as Finseta) take me through today's excellent FY23 results - reporting adjusted EBITDA of £1.7m on sales up 100% LFL to £9.6m
Eden Research unveils 78% revenue growth and key product milestones in its FY23 preliminary results, driven by the launch of its seed treatment Ecovelex and expanded regulatory approvals for flagship biopesticides.
Frontier Developments expects FY24 revenue to exceed £85m with an improved adjusted EBITDA, buoyed by robust game sales and strategic restructuring efforts.